The Flowr Corporation

The Flowr Corporation

The Flowr Corporation - Cultivating better, everywhere we grow..

HQ location
Toronto, Canada
Launch date
Employees
Market cap
$7.8m
Enterprise value
$24m
Share price
CAD0.03 FLWR.V
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
N/A

€0.0

round

CAD1.0m

Post IPO Equity
Total Funding000k
Notes (0)
More about The Flowr Corporation
Made with AI
Edit

The Flowr Corporation, a Canadian cannabis company, was established in 2016 and had its headquarters in Toronto, with its primary cultivation campus located in Kelowna, British Columbia. The company was co-founded by Tom Flow, a recognized figure in the cannabis industry who also co-founded MedReleaf, which was later acquired by Aurora Cannabis. Flow's expertise in designing and operating large-scale cannabis cultivation facilities was a foundational element of the company's strategy. The company went public on the TSX Venture Exchange in September 2018 through a reverse takeover.

Flowr's business was centered on the cultivation, production, and sale of premium cannabis products for both the medical and adult-use recreational markets. It operated a purpose-built, GMP-designed indoor cultivation facility in Kelowna, engineered to produce high-quality, non-irradiated cannabis. The business model focused on maximizing crop yield and quality to achieve profitability. The company marketed its products under several brands, including 'Flowr' for the premium adult-use market, 'FlowrRx' for the medicinal market, and 'Ace Valley,' a brand developed in partnership to target millennial consumers. Initially focused on Canada, with supply agreements in major provinces like British Columbia and Ontario, Flowr expanded its operations internationally to Europe and Australia through its subsidiary Holigen.

A significant milestone for Flowr was its exclusive R&D alliance with Hawthorne Canada, a subsidiary of The Scotts Miracle-Gro Company. This partnership led to the construction of a 50,000-square-foot R&D facility on Flowr's Kelowna campus, dedicated to advancing cannabis cultivation techniques, including lighting, irrigation, and genetics. However, the company faced significant financial challenges. In 2022, Flowr began selling major assets, including its Portugal-based subsidiary Holigen to Akanda Corp. and its Kelowna R&D facility back to Hawthorne. By October 2022, the company and its subsidiaries filed for creditor protection under the Companies' Creditors Arrangement Act (CCAA). This was followed by the sale of substantially all of its remaining assets to Avant Brands K1 Inc. in December 2022. In February 2023, the company's officers and directors resigned, and a request was made to delist its shares from the TSX Venture Exchange, marking the end of its operations as a going concern.

Keywords: The Flowr Corporation, Tom Flow, Canadian cannabis, Kelowna cultivation, premium cannabis, MedReleaf, Hawthorne Gardening, Scotts Miracle-Gro, FlowrRx, Ace Valley, Holigen, CCAA, creditor protection, Avant Brands, cannabis cultivation, adult-use cannabis, medical cannabis, GMP facility, R&D alliance, cannabis genetics, BC Pink Kush

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by The Flowr Corporation

Edit
Terrace Global
ACQUISITION by The Flowr Corporation Oct 2020